Rapid and long lasting reduction of the hypothermic effect of a D2 dopamine agonist after an intracerebroventricular injection of 6-hydroxydopamine.
In mice pretreated intracerebroventricularly (i.c.v.) with 6-hydroxydopamine (6OHDA) (50 micrograms per mouse), as soon as the hypothermia elicited by the neurotoxin had vanished (3 hr), the hypothermic effect induced by the direct D2 dopamine receptor agonist RU 24926 (1 mg/kg, s.c.), was almost completely suppressed. This reduction in hypothermic effect was observed more than 1 month after the 6OHDA injection. On the 3rd day after 6OHDA injection, this reduction was observed for all tested doses of RU 24926 (0.25-2 mg/kg). It was prevented when an i.p. administration of the norepinephrine uptake inhibitor desipramine (20 mg/kg) was performed 30 min before the 6OHDA i.c.v. injection. It was not modified when an i.p. administration of the dopamine uptake inhibitor GBR 12783 (20 mg/kg) was performed 30 min before the 6OHDA i.c.v. injection. The 6OHDA i.c.v. injection modified significantly neither the dopamine nor the serotonin hypothalamic contents. On the contrary it resulted in a marked decrease (-73%) of the norepinephrine hypothalamic content, which was unchanged by the administration of GBR 12783 (20 mg/kg, i.p.) 30 min before 6OHDA, but completely prevented by desipramine (20 mg/kg, i.p.) 30 min before 6OHDA i.c.v. injection. It is concluded that the hypothermic effect resulting from the stimulation of D2 dopamine receptors involves a central norepinephrine transmission, which is very rapidly altered after 6OHDA administration.
Suaudeau
C
C
Unité de Neuropsychopharmacologie expérimentale, U.R.A. 1170 C.N.R.S., Faculté de Médecine et Pharmacie de Rouen, Saint-Etienne du Rouvray, France.
Dourmap
N
N
Costentin
J
J
D000818:Animals; D003891:Desipramine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007035:Hypothermia / Q000139:chemically induced*; D007278:Injections, Spinal; D008297:Male; D051379:Mice; D016627:Oxidopamine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D017448:Receptors, Dopamine D2 / Q000819:agonists*; D013997:Time Factors
D010627:Phenethylamines; D017448:Receptors, Dopamine D2; C025254:RU 24926; D016627:Oxidopamine; D003891:Desipramine